全球靶向定序和定序市场规模、份额、趋势和成长分析报告（2026-2034）

预计目标定序和定序市场将从 2025 年的 105.7 亿美元成长到 2034 年的 686.4 亿美元，2026 年至 2034 年的复合年增长率为 23.1%。

受基因组学和个人化医疗发展趋势的推动，全球标靶定序和定序市场正经历显着成长。癌症诊断、罕见疾病和遗传性疾病研究的日益增多，加速了标靶定序技术的应用。研究机构和临床检查室对经济高效且精准的基因分析工具的需求也日益增长。

成长要素包括定序成本降低、生技研发投入增加以及次世代定序（NGS）应用范围不断扩大。製药公司越来越多地利用标靶定序进行药物发现和开发。精准医疗和伴随诊断日益受到关注，进一步推动了全球市场需求。

展望未来，持续的技术创新和生物资讯学工具的整合有望提高数据准确性和处理速度。在新兴市场，随着医疗基础设施的完善，预计应用范围将进一步扩大。随着基因组研究的不断深入和人们对基因检测认识的不断提高，该市场具有强劲的长期成长潜力。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章 全球标靶定序与定序市场：依技术划分

• 市场分析、洞察与预测
• 定序
• 重测序

第五章 全球标靶定序与定序市场：依应用划分

• 市场分析、洞察与预测
• 临床应用
• 植物和动物科学
• 药物研发
• 其他的

第六章 全球标靶定序与定序市场：按类型划分

• 市场分析、洞察与预测
• 基于DNA的标靶定序
• 基于RNA的标靶定序

第七章 全球标靶定序与定序市场：依最终用途划分

• 市场分析、洞察与预测
• 医院和诊所
• 学术研究
• 其他的

第八章 全球标靶定序与定序市场：按地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第九章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第十章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Agilent Technologies
  • Illumina Inc
  • F. Hoffmann-La Roche Ltd
  • Thermo Fisher Scientific Inc
  • Dnastar Inc
  • PacBio
  • Bio-Rad Laboratories Inc
  • Integrated DNA Technologies Inc
  • Perkin Elmer Inc
  • RainDance Technologies Inc
  • PierianDx

The Targeted Sequencing And Resequencing Market size is expected to reach USD 68.64 Billion in 2034 from USD 10.57 Billion (2025) growing at a CAGR of 23.1% during 2026-2034.

The Global Targeted Sequencing and Resequencing Market is experiencing significant growth driven by advancements in genomics and personalized medicine. Increasing research activities in cancer diagnostics, rare diseases, and genetic disorders have accelerated the adoption of targeted sequencing technologies. The demand for cost-effective and accurate gene analysis tools is expanding across research institutions and clinical laboratories.

Growth drivers include declining sequencing costs, rising investment in biotechnology research, and the growing application of next-generation sequencing (NGS). Pharmaceutical companies are increasingly using targeted resequencing for drug discovery and development. The expanding focus on precision medicine and companion diagnostics is further strengthening market demand worldwide.

Looking forward, continuous technological innovation and integration of bioinformatics tools are expected to enhance data accuracy and processing speed. Emerging markets are likely to witness increased adoption due to improving healthcare infrastructure. With ongoing advancements in genomics research and rising awareness about genetic testing, the market holds strong long-term growth potential.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Technology

• Sequencing
• Re-Sequencing

By Application

• Clinical Application
• Plant And Animal Sciences
• Drug Development
• Others

By Type

• DNA-Based Targeted Sequencing
• RNA-Based Targeted Sequencing

By End-Use

• Hospitals & Clinics
• Academic Research
• Others

COMPANIES PROFILED

• Agilent Technologies, Illumina Inc, F HoffmannLa Roche Ltd, Thermo Fisher Scientific Inc, Dnastar Inc, PacBio, BioRad Laboratories Inc, Integrated DNA Technologies Inc, Perkin Elmer Inc, RainDance Technologies Inc, PierianDx
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL TARGETED SEQUENCING AND RESEQUENCING MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Technology
• 4.2. Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Re-Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL TARGETED SEQUENCING AND RESEQUENCING MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Clinical Application Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Plant And Animal Sciences Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Drug Development Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL TARGETED SEQUENCING AND RESEQUENCING MARKET: BY TYPE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Type
• 6.2. DNA-Based Targeted Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. RNA-Based Targeted Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL TARGETED SEQUENCING AND RESEQUENCING MARKET: BY END-USE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End-use
• 7.2. Hospitals & Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Academic Research Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL TARGETED SEQUENCING AND RESEQUENCING MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Technology
  • 8.2.2 By Application
  • 8.2.3 By Type
  • 8.2.4 By End-use
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Technology
  • 8.3.2 By Application
  • 8.3.3 By Type
  • 8.3.4 By End-use
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Technology
  • 8.4.2 By Application
  • 8.4.3 By Type
  • 8.4.4 By End-use
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Technology
  • 8.5.2 By Application
  • 8.5.3 By Type
  • 8.5.4 By End-use
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Technology
  • 8.6.2 By Application
  • 8.6.3 By Type
  • 8.6.4 By End-use
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL TARGETED SEQUENCING AND RESEQUENCING INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Agilent Technologies
  • 10.2.2 Illumina Inc
  • 10.2.3 F. Hoffmann-La Roche Ltd
  • 10.2.4 Thermo Fisher Scientific Inc
  • 10.2.5 Dnastar Inc
  • 10.2.6 PacBio
  • 10.2.7 Bio-Rad Laboratories Inc
  • 10.2.8 Integrated DNA Technologies Inc
  • 10.2.9 Perkin Elmer Inc
  • 10.2.10 RainDance Technologies Inc
  • 10.2.11 PierianDx